Understanding the risks and taking preventive measures can help you avoid unwanted complications
The most widely discussed newer agents are semaglutide (brand name Wegovy), a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the MHRA for chronic weight management in adults, and tirzepatide (brand name Mounjaro), a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that has also received UK approval for weight management in adults
United States Code: Federal Food, Drug, and Cosmetic Act, 21 U.S.C
Do not increase your dose ahead of schedule just because the starting dose feels inactive
But if you are taking a glucagon-like peptide-1 drug better known as GLP-1 for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics
Without lifestyle changes, some people regain weight after stopping